![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
XORTX Therapeutics Inc | CSE:XRX | CSE | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.80 | 3.24 | 24.00 | 0 | 00:00:00 |
Xerox Corporation Cynthia B. Johnston, 203-968-3489 Fax: 203-968-3944 Cindy.Johnston@usa.xerox.com or Darlene Caldarelli, 203-968-3807 Fax: 203-968-3944 Darlene.Caldarelli@usa.xerox.com The Xerox Corporation (NYSE:XRX) Retirement Income Guarantee Plan has reached an agreement in principle to settle the pension-related Berger v. RIGP litigation. The terms of the proposed agreement require RIGP to settle the case for $239 million. The final settlement is subject to the negotiation of a definitive agreement and court approval. In April, Xerox reported a first-quarter pre-tax charge of $300 million to cover any potential pension-funding shortfall should RIGP be required to pay damages in this case. If the court approves the final agreement, RIGP will pay the settlement amount from its assets. Should the company need to make a cash contribution to compensate for a potential shortfall in the plan related to this litigation, it would not be required to begin doing so until 2005. RIGP is the primary pension plan for Xerox's salaried employees in the United States. On July 25, 2000, a lawsuit was filed against RIGP in the United States District Court for the Southern District of Illinois. The plaintiffs claim that the plan improperly calculated lump-sum distributions from cash balance retirement accounts, resulting in lower benefits for certain employees who left the company between Jan. 1, 1990, and Dec. 31, 1999. Former Xerox employees who are eligible to receive damages will receive notification when the settlement is approved. For additional information about The Document Company Xerox, please visit our Worldwide Web site at www.xerox.com/investor. This release contains forward-looking statements and information relating to Xerox that are based on our beliefs as well as assumptions made by and information currently available to us. The words "anticipate," "believe," "estimate," "expect," "intend," "will" and similar expressions, as they relate to us, are intended to identify forward-looking statements. Actual results could differ materially from those projected in such forward-looking statements. Information concerning certain factors that could cause actual results to differ materially is included in the company's Form 10-Q for the quarter ended September 30, 2003, as filed with the SEC. XEROX(R), The Document Company(R) and the digital X(R) are trademarks of XEROX CORPORATION.
1 Year XORTX Therapeutics Chart |
1 Month XORTX Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions